ENDRA Life Sciences Inc. financial data

Symbol
NDRA on Nasdaq
Location
Ann Arbor, MI
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 334% % -10%
Quick Ratio 0% % -100%
Debt-to-equity 108% % 375%
Return On Equity -538% % -280%
Return On Assets -258% % -124%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,166,441 shares
Common Stock, Shares, Outstanding 786,902 shares 47%
Common Stock, Value, Issued $77 USD 45%
Weighted Average Number of Shares Outstanding, Basic 761,218 shares 208%
Weighted Average Number of Shares Outstanding, Diluted 761,218 shares 208%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $1,979,816 USD -37%
Selling and Marketing Expense $269,381 USD -57%
General and Administrative Expense $6,188,617 USD 47%
Operating Income (Loss) $8,437,814 USD -5.8%
Nonoperating Income (Expense) $225,256 USD 73%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $8,007,205 USD 9.2%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $8,007,205 USD 9.2%
Earnings Per Share, Basic -2.1 USD/shares 78%
Earnings Per Share, Diluted -2.1 USD/shares 78%

Balance Sheet

Label TTM Value / Value Unit Change %
Inventory, Net $0 USD -100%
Assets, Current $1,048,709 USD -79%
Property, Plant and Equipment, Net $52,633 USD -34%
Operating Lease, Right-of-Use Asset $491,363 USD 114%
Other Assets, Noncurrent $5,986 USD
Assets $1,964,108 USD -77%
Accounts Payable, Current $252,491 USD -9.6%
Employee-related Liabilities, Current $152,556 USD 14%
Liabilities, Current $800,307 USD -1.7%
Operating Lease, Liability, Noncurrent $396,537 USD 696%
Liabilities $1,792,728 USD 1%
Retained Earnings (Accumulated Deficit) $107,296,300 USD -8.1%
Stockholders' Equity Attributable to Parent $171,380 USD -97%
Liabilities and Equity $1,964,108 USD -77%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,293,129 USD 40%
Net Cash Provided by (Used in) Financing Activities $145,803 USD -69%
Net Cash Provided by (Used in) Investing Activities $17,280 USD 27%
Common Stock, Shares Authorized 20,000,000 shares 0%
Common Stock, Shares, Issued 786,902 shares 47%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $794,036 USD -83%
Interest Paid, Excluding Capitalized Interest, Operating Activities $14,855 USD 69%
Operating Lease, Liability $525,328 USD 122%
Depreciation $10,786 USD -6.2%
Payments to Acquire Property, Plant, and Equipment $17,280 USD -36%
Lessee, Operating Lease, Liability, to be Paid $625,802 USD 147%
Operating Lease, Liability, Current $128,791 USD -31%
Lessee, Operating Lease, Liability, to be Paid, Year One $91,670 USD -9.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $100,474 USD 523%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $107,467,603 USD 1.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%